Clinical trials: Metabolic Risk Factors
Venous Thrombosis, Insulin Resistance
Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
Ultra-low-dose oral E2/D will have more beneficial effects than trans-dermal HRT on lipids and insulin resistance in postmenopausal women, whilst adverse effects on coagulation will be avoided.
- Trial name
- OPTIMISE (NCT02264743)
- Testing
- Femoston Conti, EVOREL® CONTI
- Where
- 3 sites in United Kingdom
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
Visceral Adiposity Index
Visceral Adiposity Index and Overactive Bladder
In present study, we aimed to investigate the association between visceral adiposity index and overactive bladder symptoms in female patients aged over 18 years.Between January-2015 and July-2017, 151 female patient with…
- Trial name
- NCT03280654
- Testing
- overactive bladder
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- Recep Tayyip Erdogan University Training and Research Hospital
Cardiometabolic Risk Factors
Metabolic Wellness and CGM
The primary objective of this study is to determine the impact of participating in an online lifestyle intervention program on glycemic control as measured by Continuous Glucose Monitoring (CGM), with the primary outcome being…
- Trial name
- NCT06790472
- Testing
- Online Lifestyle Intervention, Continuous Glucose Monitoring
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- David Kerr
Hypercholesterolemia
Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)
The overall objective is to evaluate the efficacy and safety of ezetimibe (SCH 058235/MK-0653) 10 mg administered daily in conjunction with atorvastatin in participants with Heterozygous Familial Hypercholesterolemia (HeFH) or in…
- Trial name
- NCT03867318
- Testing
- Atorvastatin, Ezetimibe
- Volunteers
- 621 people
- Sponsor
- Organon and Co
Metabolic Syndrome, Vascular Disorders
Optimal Timing of Physical Activity in Cancer Treatment
The number of long-term cancer survivors is growing. As a result, treatment-related morbidity - such as cardiovascular disease, metabolic syndrome, functional decline and fatigue - is impacting quality of life and impairing…
- Conditions
- Metabolic Syndrome, Vascular Disorders, Cardiovascular Risk Factors, Fatigue
- Trial name
- ACT (NCT01642680)
- Testing
- A tailored physical activity program during chemotherapy, A tailored physical activity program after chemotherapy
- Where
- Netherlands
- Volunteers
- 266 people
- Sponsor
- University Medical Center Groningen
Bronchiolitis, Seizures
Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis
Bronchiolitis is the leading cause of pediatric intensive care unit admission in infants. Seizures during bronchiolitis may be a neurological complication of respiratory viruses but also of the treatments.
- Conditions
- Bronchiolitis, Seizures, Hyponatremia
- Trial name
- BRONCHIOLITIS (NCT04022486)
- Testing
- Incidence, management and risk factors of seizure
- Where
- France
- Volunteers
- 805 people
- Sponsor
- Hospices Civils de Lyon
Psoriasis, Cardiovascular Diseases
The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
Psoriasis vulgaris is no longer considered as a chronic inflammatory disease restricted to the skin. Evidence has accumulated in the past that psoriasis is a chronic inflammatory systemic disease.
- Conditions
- Psoriasis, Cardiovascular Diseases, Diabetes Mellitus, Type 2
- Trial name
- CASTIP (NCT01088165)
- Testing
- Adalimumab treatment arm, Fumaric acid esters treatment group, Narrow band UVB radiation
- Where
- Austria
- Volunteers
- 66 people
- Sponsor
- Medical University of Vienna
Healthy
The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
In humans and most mammals, bile acids play a role in the metabolism of glucose and the transport and absorption of lipids (such as cholesterol and triglycerides), vitamins, and nutrients by allowing for emulsification (mixing)…
- Trial name
- BioMet-7 (NCT07499414)
- Testing
- 7-KLCA, Maltodextrin
- Where
- United Kingdom
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Reading
Lung Cancer, Nonsmall Cell
Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients
Non-small cell lung cancer (NSCLC) accounts for more than two-thirds of lung cancer, which is the leading cause of cancer deaths in Taiwan. The overall prognosis of NSCLC is poor with low 5-year survival rates.
- Trial name
- NCT03504098
- Testing
- nutrition consult
- Where
- Taiwan
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Cardiovascular Diseases, Diabetes Mellitus, Type 2
Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians
Cardiovascular disease (CVD) is a serious health concern for American Indians, but there have been few behaviorally based programs to lessen CVD risk among this population.
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension, Obesity
- Trial name
- NCT00608387
- Testing
- Chronic disease management Web-based software
- Where
- United States
- Volunteers
- 149 people
- Sponsor
- Black Hills Center for American Indian Health
Diabetes
SUPREME-DM (Diabetes Mellitis) Treatment Study
This multisite pragmatic clinical trial was designed to assess the effectiveness of a single scripted telephone call to diabetes patients who (a) were currently above recommended clinical goals for glucose, blood pressure, or…
- Trial name
- NCT02192255
- Testing
- Intervention Phone Call
- Where
- United States
- Volunteers
- 2,378 people
- Sponsor
- HealthPartners Institute
Obesity
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more. People can take part if they have cardiovascular or chronic kidney disease.
- Trial name
- NCT06077864
- Testing
- survodutide
- Where
- 542 sites in United States, Argentina and 33 more
- Volunteers
- 5,530 people
- Sponsor
- Boehringer Ingelheim
Chronic Obstructive Pulmonary Disease, Osteoporosis
Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.
Patients with COPD have been found to have an increased risk of osteoporosis. The underlying mechanism is not clear yet. This case control study aims to identify risk factors for osteoporosis in GOLD II COPD patients.
- Trial name
- NCT00725673
- Where
- Netherlands
- Volunteers
- 106 people
- Sponsor
- Catharina Ziekenhuis Eindhoven
Hypoglycemia
Analysis of Related Risk Factors of Hypoglycemia Consciousness Disorder
Objective to explore the high risk factors and inducements of consciousness disorder in patients with hypoglycemia, and to conduct a retrospective study.
- Trial name
- NCT04971070
- Testing
- Observation and follow-up
- Where
- China
- Volunteers
- 292 people
- Sponsor
- Chongqing Renji Hospital, University of Chinese Academy of Sciences
Metabolic Disease, Cardiovascular Disease
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
Background: Cardiometabolic diseases are medical disorders that can occur together and affect the heart. They increase the risk of developing heart disease and diabetes.
- Conditions
- Metabolic Disease, Cardiovascular Disease, Inflammation, Psoriasis
- Trial name
- NCT01778569
- Where
- United States
- Volunteers
- 386 people
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Olanzapine, Breast Cancer
Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors
The aim of THE STUDY to determine whether an olanzapine-based dexamethasone-sparing antiemetic regimen is non-inferior to the standard dexamethasone-containing regimen in preventing delayed-phase Chemotherapy-induced nausea and…
- Conditions
- Olanzapine, Breast Cancer, Dexamethasone
- Trial name
- NCT07743827
- Testing
- Pantoprazole, olanzapine, Dexamethasone
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Alexandria University
Cardiovascular Diseases, Coronary Disease
Coronary Heart Disease Risk Factors in Upwardly Mobile Blacks and Whites
To evaluate the relation between blood pressure and socioeconomic status, electrolyte intake, obesity and psychosocial factors in Black and white students.
- Conditions
- Cardiovascular Diseases, Coronary Disease, Hypertension, Heart Diseases
- Trial name
- NCT00005175
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Metabolic Syndrome, Obesity
A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -
The Purpose of this trial is to investigate the efficacy and safety of Daesiho-tang and Taeeumjowi-tang on Korean obese Women with metabolic syndrome Risk factors
- Trial name
- NCT02651454
- Testing
- Daesiho-tang, Chowiseungcheng-tang
- Where
- South Korea
- Volunteers
- 120 people
- Sponsor
- Gachon University Gil Oriental Medical Hospital
Metabolic Syndrome, Healthy Volunteers
The Role of a Natural Product, Containing Nanovesicles From Citrus Limon (L.) Juice, on Different CV Risk Factors
Clinical trial about beneficial effects of natural supplement in a spray-dried formulation, citraVes™, obtained from Citrus Limon (L.) juice on general body health.
- Trial name
- NCT04698447
- Testing
- Natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_MetS, Natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_HS
- Where
- Italy
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Palermo
Fabry Disease
Canadian Fabry Disease Initiative (CFDI) National Registry
CFDI NATIONAL REGISTRY Fabry disease is a rare, inherited, genetic condition due to a deficiency of an enzyme called alpha-galactosidase A.
- Trial name
- CFDI-NR (NCT00455104)
- Testing
- No intervention
- Where
- 5 sites in Canada
- Volunteers
- 600 people
- Sponsor
- Canadian Fabry Research Consortium
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.